Barr, Mylan Face Patent Suit Over Amrix ANDAs
Generic-drug makers Mylan Inc. and Barr Pharmaceuticals Inc. have been hit with a patent infringement suit over their respective efforts to make a generic version of the drug Amrix, a skeletal...To view the full article, register now.
Already a subscriber? Click here to view full article